CJC-1295 / IPAMORELIN Ipamorelin + CJC-1295 No DAC Blend · 10mg
Buy 9+
Save 25% · Every Vial
—
—
Per Vial
Ipamorelin / CJC-1295 (No DAC) is a dual-peptide research blend combining a selective GHS-R1a agonist with a GHRH analog. The pairing is studied for combined GH release and endocrine pathway modeling.
Purity >99%Form Lyophilized PowderNo Endotoxins
Notify me when back in stock
Related Products
Peer-Reviewed Literature
Related Studies
Peer-Reviewed Literature
Related Studies
Ipamorelin, the First Selective Growth Hormone Secretagogue
European Journal of Endocrinology
Foundational paper establishing ipamorelin as a selective GHS-R1a agonist. Unlike GHRP-2 and GHRP-6, ipamorelin does not stimulate ACTH or cortisol, making it uniquely selective.
Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin in Human Volunteers
Pharmaceutical Research
Dose-escalation trial demonstrated ipamorelin produces a GH release episode peaking at 0.67 hours with terminal half-life of 2 hours across five dose levels in healthy male volunteers.
Ipamorelin Induces Longitudinal Bone Growth in Rats
Growth Hormone & IGF Research
Ipamorelin dose-dependently increased longitudinal bone growth rate from 42 to 52 µm/day with pronounced dose-dependent effects on body weight gain in adult female rats.
Prolonged Stimulation of Growth Hormone and Insulin-Like Growth Factor I Secretion by CJC-1295 in Healthy Adults
Journal of Clinical Endocrinology & Metabolism
Single injection of CJC-1295 produced dose-dependent GH increases of 2–10 fold sustained for 6+ days and IGF-I elevations of 1.5–3 fold for 9–11 days, with half-life of 5.8–8.1 days.
Pulsatile Secretion of Growth Hormone Persists During Continuous Stimulation by CJC-1295
Journal of Clinical Endocrinology & Metabolism
CJC-1295 increased trough and mean GH secretion and IGF-I production while preserving physiological GH pulsatility — distinguishing it from continuous GH replacement.
Activation of the GH/IGF-1 Axis by CJC-1295 Results in Serum Protein Profile Changes in Normal Adult Subjects
Growth Hormone & IGF Research
Proteomic analysis of sera from 11 healthy men demonstrated significant protein profile changes reflecting GH/IGF-1 axis activation one week after CJC-1295 injection.
CJC-1295 / IPAMORELIN FAQ
Where do I buy the CJC 1295 ipamorelin blend?
The CJC-1295 ipamorelin blend is for sale from Blank Peptides as a single 10mg vial containing both peptides, made in our cGMP labs in the USA. A lot-matched certificate of analysis is published before you order. No prescription is involved, and processing time is within 1 business day with tracking emailed at label creation.
What is in the ipamorelin and CJC-1295 no DAC blend?
Two peptides in one lyophilized vial: ipamorelin, a selective GHS-R1a agonist, and CJC-1295 no DAC, a modified GHRH fragment. The pairing is one of the most studied combinations in growth hormone research because the two act on independent receptors, letting researchers model combined endocrine signalling rather than either pathway alone.
Why do researchers combine a GHRH analogue with a ghrelin receptor agonist?
Because the pathways converge on growth hormone release from different directions. GHRH analogues act at the GHRH receptor on somatotrophs; ipamorelin acts at the ghrelin receptor. Animal studies pairing the two have looked at whether the combined signal behaves additively or synergistically, which is a question you cannot ask with a single compound.
Is the blend tested to the same standard as single peptides?
Yes, with the assay resolving both sequences separately. Purity is greater than 99%, checked by HPLC and mass spectrometry in house and confirmed independently at Freedom Diagnostics or Horizon Analytical. Bacterial endotoxin testing runs at batch release. The COA carries the lot number from your vial.
How much bacteriostatic water for the 10mg blend vial?
1mL, our standard 1mL per 10mg ratio, giving 10mg of combined peptide per millilitre. Add the water down the inside wall of the glass and swirl slowly. Two-peptide cakes sometimes take slightly longer to clear than a single sequence, so give it a moment before assuming a problem.
Blend or separate vials of ipamorelin and CJC-1295?
The blend saves a reconstitution, a storage slot and a second draw, with the ratio fixed. Separate vials of ipamorelin and CJC-1295 no DAC are the better choice when the design needs each concentration varied independently or one arm run without the other.
How should the CJC-1295 and ipamorelin blend be stored?
Sealed lyophilized at -20C, out of light, dry. Ambient shipping temperatures are fine for freeze-dried powder. Once mixed, refrigerate at 2 to 8C and use within a few weeks. Blends lose integrity faster than single peptides under repeated freeze-thaw cycling, so aliquot if the protocol is long.
Is this blend legal to purchase for research?
It is sold in the United States as a research chemical for laboratory use, with no FDA approval for any indication. It is not a drug, supplement or veterinary product, and both components are WADA prohibited. Ordering confirms you are a qualified researcher handling it in a research setting only.
